Lv5
1210 积分 2024-01-11 加入
Advances in understanding the mechanisms of the human papillomavirus oncoproteins
2天前
已完结
Treatment advances across the cervical cancer spectrum
2天前
已完结
Regulation of immune checkpoint molecules in cancer immune evasion and therapy
2天前
已完结
PD-L1: Can it be a biomarker for the prognosis or a promising therapeutic target in cervical cancer?
2天前
已完结
Linking tumour angiogenesis and tumour immunity
2天前
已完结
The complexity of immune evasion mechanisms throughout the metastatic cascade
3天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
4天前
已完结
Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial
4天前
求助中
NSCLC: Five trials to watch
1个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
2个月前
已完结
皖公网安备34019202002308
